2018
DOI: 10.14309/00000434-201810001-00116
|View full text |Cite
|
Sign up to set email alerts
|

Anti-Protozoal Enema Treatment for Blastocystis hominis and Dientamoeba fragilis: Does Volume Matter?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Despite the controversy of pathogenicity, the symptoms have presupposed treatment if became persistent without other detected pathogens (Mokhtar et al, 2016). Many anti-protozoal drugs either single or in combination with others gave high failure rates (Le Busque et al, 2018). Although metronidazole (MTZ) is a golden blastocystosis treatment, yet with wide range of side effects as carcinogenicity, embryogenicity and teratogenicity, as well as variable inappropriate responses ranged from 0 to100% (Batista et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Despite the controversy of pathogenicity, the symptoms have presupposed treatment if became persistent without other detected pathogens (Mokhtar et al, 2016). Many anti-protozoal drugs either single or in combination with others gave high failure rates (Le Busque et al, 2018). Although metronidazole (MTZ) is a golden blastocystosis treatment, yet with wide range of side effects as carcinogenicity, embryogenicity and teratogenicity, as well as variable inappropriate responses ranged from 0 to100% (Batista et al, 2017).…”
Section: Introductionmentioning
confidence: 99%